Study Information
Locations
Not Specified
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
Study Aims
To examine the following:
(1) Cardiovascular disease (CVD) prevalence among Asians, Pacific Islander, and mixed-race Asian-Pacific Islander subpopulations.
(2) Demographic, clinical, and psychosocial factors to explain observed differences in CVD prevalence.
(3) Prevalence of secondary CVD outcomes and quality of life; demographic, clinical, and psychosocial factors explaining observed differences.
PI is Beth Waitzfelder, Ph.D., Center for Health Research at Kaiser Permanente Hawaii.
Co-PIs are (1) Stephen P. Fortmann, M.D., Kaiser Permanente Center for Health Research and Stanford School of Medicine, as well as (2) Latha Palaniappan, M.D., M.S., Stanford School of Medicine.
Site PI and Co-Investigator is Sukyung Chung, Ph.D.
To examine the following:
(1) Cardiovascular disease (CVD) prevalence among Asians, Pacific Islander, and mixed-race Asian-Pacific Islander subpopulations.
(2) Demographic, clinical, and psychosocial factors to explain observed differences in CVD prevalence.
(3) Prevalence of secondary CVD outcomes and quality of life; demographic, clinical, and psychosocial factors explaining observed differences.
PI is Beth Waitzfelder, Ph.D., Center for Health Research at Kaiser Permanente Hawaii.
Co-PIs are (1) Stephen P. Fortmann, M.D., Kaiser Permanente Center for Health Research and Stanford School of Medicine, as well as (2) Latha Palaniappan, M.D., M.S., Stanford School of Medicine.
Site PI and Co-Investigator is Sukyung Chung, Ph.D.
Principal Investigator
External PI, Principal Investigator
Co-Investigator(s)
Funder
National Heart, Lung, and Blood Institute
Related Studies
COVID-19 Impacts on Cancer Care Management, Patient Experience and Care Costs
Project goals: To understand impacts of COVID-19 on cancer care management (detection, diagnosis, treatment), pt-reported experience, and cancer care costs.
Investigators: Cheryl Stults, Ph.D., Su-Ying Liang, Ph.D., Monique de Bruin, M.D., MPH
Stupski Serious Illness Program Evaluation
Evaluate palliative care projects at seven healthcare organizations in the SF Bay Area.
Investigator: Sylvia Sudat, PhD
Impact of COVID-19 on Cancer Care Management
Study will enhance understanding of cancer care management due to COVID-19.
Investigators: Su-Ying Liang, Ph.D., Monique de Bruin, M.D., MPH
Quantifying 2D and 3D MRI Imaging For Improving MS Diagnosis, Treatment, And Clinical Care
Create a longitudinal proof-of-concept MS research database (MSClinQ) that can support clinical queries, and can be updated with new tx, dx tools, care options
Investigators: J.B. Jones, PhD, MBA, Xiaowei (Sherry) Yan, PhD, MS
Improving Cancer Care
Project will provide information about referrals to palliative care and way to enhance goals of care discussions for patients diagnosed with stage IV cancer.
Investigator: Su-Ying Liang, Ph.D.
Major Depressive Disorder
Purpose is to use EHR to understand the management of major depressive disorder in a large healthcare system, to incorporate pt-reported data in care workflow.
Investigator: Kristen M.J. Azar, R.N., BSN, MSN/MPH
Using Mobile Technology and Analytics to Track Outcomes in MS Patients
Develop an app to collect and transform pt-reported outcomes in MS for health care providers to improve care and support shared decision making.
Investigators: Xiaowei (Sherry) Yan, PhD, MS, J.B. Jones, PhD, MBA
Transforming Primary and Specialty Care for Inflammatory Bowel Disease
Use healthcare data to personalize the healthcare experience for people with inflammatory bowel disease.
Implementing Universal Lynch Syndrome Screening Across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizations Contexts
To describe and explain variations in Lynch syndrome (LS) screening implementation across healthcare systems and create a toolkit for implementing LS screening.
Investigators: Su-Ying Liang, Ph.D., External PI, Principal Investigator, Monique de Bruin, M.D., MPH
Evaluation of a Lifestyle Intervention Adopted for Clinical Practice for Diabetes Prevention (ELEVATE-DP)
This study will identify important barriers to and facilitators of translating an efficacious diabetes prevention intervention (Group Lifestyle Balance, GLB)
Investigators: Sylvia Sudat, PhD, Kristen M.J. Azar, R.N., BSN, MSN/MPH